We aim to deliver growth and create value for our shareholders
Investors
Information for investors including financial results and shareholder information.
link for e-mail registration for shareholders
| Registered office |
|---|
| GlaxoSmithKline Pharmaceuticals Limited CIN : L24239MH1924PLC001151 Dr. Annie Besant Road Worli Mumbai- 400030 Tel: +91 22 2495 9595 Fax: +91 22 2495 9494 Email ID: in.investorquery@gsk.com |
| Registrar and share transfer agents: |
|---|
| KFin Technologies Pvt. Ltd. Selenium Tower B, Plot 31 & 32, Financial District, Nanakramguda, Serilingampally Mandal, Hyderabad - 500 032, Telangana. Email: einward.ris@kfintech.com Website: www.kfintech.com and / or ris.kfintech.com Toll free number: 1- 800-309-4001 |
Shareholder information
The hub for miscellaneous information and resources relevant to our shareholders
ESG
At GSK, our ESG approach supports our aim to create long-term value for shareholders and meet the needs of society.
